Results 171 to 180 of about 53,065 (244)

Malignant carcinoid syndrome treated by resection of hepatic metastases

The American Journal of Surgery, 1965
Summary Resection of metastatic carcinoid tumors in the liver resulted in complete immediate remission of incapacitating symptoms of the malignant carcinoid syndrome in a patient who had primary carcinoid tumor of the lung. * *Addendum: Nine months after resection of hepatic metastases, mild flushing attacks recurred.
James H. Foster, James J. Chandler
semanticscholar   +5 more sources

Metastatic Carcinoid Tumors and the Malignant Carcinoid Syndrome [PDF]

Annals of the New York Academy of Sciences, 1994
Patients with metastatic carcinoid tumors and the malignant carcinoid syndrome have benefited immensely from diagnostic and therapeutic advances during the past decade. Magnetic resonance imaging and whole body scintigraphy with radiolabelled analogues of somatostatin have improved our ability to diagnose, detect, stage and follow response to therapy ...
L. Kvols
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Cutaneous manifestations of the malignant carcinoid syndrome

British Journal of Dermatology, 2005
The incidence of carcinoid tumours is approximately 1.5 per 100 000 of the population. The malignant carcinoid syndrome, which is caused by circulating neuroendocrine mediators produced by the tumour, occurs in less than 10% of patients. Cutaneous involvement, although recognized in this rare syndrome, has rarely been reported.To examine a series of ...
H.K. Bell, G.J. Poston, N.J.E. Wilson, Jiten Vora   +3 more
openaire   +4 more sources

Treatment of the carcinoid tumor and the malignant carcinoid syndrome.

Journal of Clinical Oncology, 1983
Certainly in treatment of the carcinoid tumor surgery has a well-established curative and palliative potential. The primary challenge is a knowledgable marriage between stage of disease and aggressiveness of operative procedure. Nonsurgical treatment of the malignant disease per se has thus far not produced optimum results and, in the opinion of this ...
C. Moertel
openaire   +4 more sources

Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.

Journal of Clinical Oncology, 1989
Twenty-seven patients with metastatic carcinoid tumor, 24 of whom had the malignant carcinoid syndrome, were treated with recombinant leukocyte A interferon at a planned dose of 24 x 10(6) U/m2. Twenty percent of patients with measurable tumor experienced an objective regression and 39% of those with the carcinoid syndrome experienced a reduction of ...
Charles G. Moertel, Joseph Rubin, Larry K. Kvols   +2 more
openaire   +4 more sources

Therapy of the Malignant Carcinoid Syndrome

Endocrinology and Metabolism Clinics of North America, 1989
Although usually associated with carcinoid tumors of the small intestine that have metastasized to the liver, the carcinoid syndrome is seen less frequently with primary tumors arising from other organs such as the lung, pancreas, thymus, stomach, and ovary.
L. Kvols
openaire   +4 more sources

Treatment of the Malignant Carcinoid Syndrome

Survey of Anesthesiology, 1986
We studied the effects of a long-acting analogue of somatostatin (SMS 201-995, Sandoz) in 25 patients with histologically proved metastatic carcinoid tumors and the carcinoid syndrome. This drug was self-administered by subcutaneous injection at a dose of 150 micrograms three times daily. Flushing and diarrhea associated with the syndrome were promptly
Joseph Rubin, Michael J. O'Connell, Larry K. Kvols, Charles G. Moertel, Allan J. Schutt, Richard G. Hahn   +5 more
openaire   +5 more sources

Malignant Carcinoid Syndrome Associated with Noncarcinoid Tumors

New England Journal of Medicine, 1965
DURING the past decade the "malignant carcinid syndrome" has been a favored subject in the medical literature because of the dramatic nature of its acute and chronic clinical manifestations and of its as yet unresolved challenges to the physiologist and therapist.
Oliver H. Beahrs, Gertrude M. Tyce, Charles G. Moertel, Lewis B. Woolner   +3 more
openaire   +3 more sources

Abdominal Crisis in the Malignant Carcinoid Syndrome

Archives of Internal Medicine, 1966
EPISODES of acute abdominal pain during the course of the malignant carcinoid syndrome often present a major challenge to physicians caring for patients with this unique disease. The primary tumor (usually in the small intestine) rarely causes symptoms until widespread metastases occur.
C. E. Mengel
  +6 more sources

Treatment of Malignant Carcinoid Syndrome With a Long-Acting Somatostatin Analogue

Archives of Dermatology, 1989
A patient with malignant carcinoid syndrome was treated with a long-acting somatostatin analogue. The cutaneous and systemic improvement our patient had while receiving this therapy is described.
Jaime A. Tschen, Andrew R. Altman, Lawrence Rice   +2 more
openaire   +4 more sources